This attenuates NK cell responses that depend on recognition of antigen, including activation of tumor necrosis factor (TNF) receptor superfamily member 6 (CD95) and TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis pathways, thus protecting tumor cells from immune cell attack [148,150]. This evidence concerns the gene TNFSF10 and neoplasm.